Skip to main content
TRT
PROVIDER
GUIDE
RESOURCE

TRT and Sleep Apnea: Can You Take Testosterone If You Have Sleep Apnea?

TRT and sleep apnea can coexist, but testosterone may worsen nighttime breathing. The Endocrine Society recommends against starting TRT with untreated severe obstructive sleep apnea. Treated or milder apnea is not automatic clearance: a clinician still needs to confirm low testosterone, assess other risks, and plan sleep and hematocrit monitoring.

By TRT Provider Guide · Last verified: October 2026 · Medical review status: Evidence-cited educational content; not medically reviewed.

Last updated: .

Sources: Endocrine Society guideline and Testim prescribing information, §5.12.

One blood test to ask about is hematocrit, the share of your blood made of red blood cells. Not every starter hormone kit lists it. We'll show you which published panels do, which don't, and what to ask before paying. A normal result does not rule out sleep apnea or clear you for TRT. Monitoring guidance · Sleep-testing guidance

This page is a good fit if:

  • You have sleep apnea, or you snore and feel wiped out, and you want to know if TRT is still an option.
  • You're already on TRT and your snoring, sleepiness, or hematocrit has changed.
  • You use a CPAP and want to know what to bring to a TRT consult.

Start with primary care or a sleep clinician before shopping for TRT if:

  • You've been told your apnea is severe and you aren't treating it.
  • You snore loudly and are sleepy during the day, but you've never been tested.

Already on TRT and breathing worse at night? Contact your prescriber promptly and involve your sleep clinician rather than switching clinics. Testim patient counseling, §17.3

Safety first: If you are struggling to breathe right now, call 911. If you are fighting to stay awake behind the wheel, pull over and don't drive again until this is checked. Sleep apnea and drowsy driving are a dangerous mix, and no hormone question is more urgent than that. Sleep-apnea safety guidance

This page is educational information, not medical advice. It does not diagnose sleep apnea or low testosterone, and it can't clear anyone for treatment.

Scope: Adult male hypogonadism. This page does not cover gender-affirming testosterone care, treatment in women or adolescents, or nonmedical performance use.

TRT and sleep apnea: which situation fits you?

Sleep apnea isn't one situation. The next step depends on whether apnea is suspected, treated, untreated, or changing while you take testosterone. These nine situations help you plan a clinician conversation; none establishes treatment eligibility.

Find the row that sounds like you.

TRT and sleep apnea table 1: TRT and sleep apnea: which situation fits you?
Your situation What guidelines and labels say What to do before paying for TRT Best place to start
1. No snoring, no witnessed breathing pauses, not sleepy No symptoms does not rule out apnea or other TRT risks. A sleep study is not required for every candidate. Review symptoms and health history; confirm consistently low testosterone with appropriate repeat morning testing. Primary care or another clinician who evaluates testosterone deficiency
2. Loud snoring or daytime sleepiness, never tested Sleep disorders can overlap with symptoms attributed to low testosterone. A questionnaire cannot diagnose apnea. Ask whether you need a sleep test while your clinician evaluates possible low testosterone. Primary care or a sleep clinic
3. Diagnosed mild sleep apnea Mild apnea alone is not the guideline's untreated severe exclusion. That does not establish TRT eligibility. Ask how apnea treatment, symptoms, and hematocrit will be reviewed. A clinician who can coordinate testosterone and sleep care
4. Moderate apnea, treated and shown to be controlled The recommendation names untreated severe apnea, not all treated apnea. Bring your sleep report, treatment follow-up data, and a recent blood count. Your evaluating clinician, with sleep-medicine input as needed
5. Severe apnea, treated and working The guideline's bar is untreated severe apnea; other risks still matter. Show that treatment is working, get a baseline hematocrit, and loop in your sleep doctor. Coordinated sleep and testosterone care; local care when health needs are complex
6. Severe apnea without effective treatment The Endocrine Society recommends against starting TRT. Address the apnea before a new testosterone prescription. CPAP is not the only possible prescribed treatment. Primary care or a sleep clinic, not a TRT sales intake
7. Already on TRT, with new snoring, gasping, or worse fatigue Labels warn testosterone may worsen sleep apnea and tell patients to report breathing changes. Tell your prescriber promptly. Ask about a sleep test and a hematocrit check. Your prescriber plus sleep medicine
8. Already on TRT, with hematocrit climbing Guidance pairs a high hematocrit on TRT with checking for low oxygen and sleep apnea. Ask about sleep apnea, not just a dose change. Your prescriber
9. Moderate apnea that is untreated or not controlled This is not the specific untreated severe exclusion, but it is not evidence that starting TRT is safe. Ask your sleep clinician and testosterone prescriber to review treatment needs and risks together. Primary care or sleep medicine, working with the clinician evaluating low testosterone

This table helps you organize your next step. It can't tell you whether you have sleep apnea or low testosterone. Diagnosis requires a clinician's assessment and the right tests, not symptoms or test results alone.

The care-route suggestions are our editorial judgment based on the Endocrine Society guideline, AASM diagnostic guideline, and Testim label.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, sleep medicine, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

Not sure which row is yours? Use the tool to organize questions about testing, fertility, insurance, budget, and online or local care. The tool is educational and doesn't diagnose anything or approve treatment; it does not assess whether your apnea is controlled. Use Find My TRT Path to plan your care-route questions →

Read our privacy policy before sharing information.

Can you take TRT if you have sleep apnea?

Answer: Sleep apnea does not automatically rule out TRT, but treated or milder apnea does not automatically make it appropriate. The Endocrine Society's 2018 guideline lists "untreated severe obstructive sleep apnea" among the conditions where it recommends against testosterone therapy. FDA-approved labeling also warns that testosterone may worsen sleep apnea in some men, especially those with obesity or chronic lung disease. Guideline · Label, §5.12

The sleep-apnea wording is specific. It doesn't say "sleep apnea." It says untreated and severe. Both words matter.

What "severe" means

Doctors grade obstructive sleep apnea (OSA) by the apnea-hypopnea index (AHI). AHI is the number of times per hour your breathing stops or gets very shallow while you sleep.

TRT and sleep apnea table 2: What "severe" means
Severity AHI (events per hour)
Mild 5 to fewer than 15
Moderate 15 to fewer than 30
Severe 30 or more

These are adult ranges. AHI definitions and limits

Your sleep study report lists a breathing-event measure; a home test may report a respiratory event index (REI) rather than AHI. If you don't know yours, ask for the report. You'll want it for any TRT consult. AASM diagnostic guideline

What "treated" really means

Owning a CPAP machine isn't the same as treated apnea. Neither is having a prescription for one. For CPAP (continuous positive airway pressure), NHLBI advises using it every time you sleep, including naps. Your sleep clinician also needs to assess whether your prescribed treatment is controlling your breathing; a device-use count alone is not proof. CPAP data can show hours used and estimate remaining breathing events, so bring that summary to your visit. NHLBI CPAP guidance · Limits of device AHI

If CPAP has been miserable for you, you're not alone. Mask fit, pressure settings, and other options like oral devices are worth working through. Bring them to your sleep clinician. Untreated because it's uncomfortable still counts as untreated. CPAP support options

There is no fixed number of nights on CPAP in the Endocrine Society guideline that clears someone for TRT. The question is whether apnea is controlled and the rest of the testosterone evaluation supports treatment. Guideline

What the label actually says

The FDA-approved label for testosterone cypionate injection says testosterone "may potentiate sleep apnea in some patients, especially those with risk factors such as obesity or chronic lung diseases." That archived label is revised June 2022; the currently posted Testim gel label, revised July 2025, also retains the warning and tells patients to report breathing problems during sleep. Cypionate label, §5.10 · Testim, §§5.12 and 17.3

In the Testim label, sleep apnea is a warning, not a listed contraindication. A contraindication is a labeled reason not to use a drug; this version of the Testim label lists breast cancer and known or suspected prostate cancer among them. That label distinction does not cancel the guideline recommendation against starting TRT with untreated severe apnea. Testim, §§4 and 5.12 · Endocrine Society

Central sleep apnea is a different problem

The TRT studies summarized here are about obstructive sleep apnea. That's when the airway collapses during sleep. Central sleep apnea happens when the brain doesn't send the signal to breathe. If you've been told you have central apnea, that needs its own evaluation with a sleep specialist before any TRT decision. Central sleep apnea

Does TRT make sleep apnea worse?

Answer: It can, in some men, but the available studies do not predict an individual's response. In a controlled trial of obese men with severe sleep apnea, nighttime oxygen measures worsened at 7 weeks; the between-group differences were not statistically significant at 18 weeks, which does not prove the risk disappeared. A large U.S. records study found more new sleep apnea diagnoses in men on TRT, but it couldn't prove TRT caused them. Hoyos trial · Cole cohort

We pulled the key studies into one table so you can see who was studied, what they got, and what happened. The table keeps results from different populations and study designs separate.

What the research actually shows

TRT and sleep apnea table 3: What the research actually shows
Study Who was studied What they took How long What happened What it means for you
Matsumoto et al., 1985 5 men with low testosterone Testosterone enanthate injections every 2 weeks 6 weeks Sleep apnea appeared in 1 man and got much worse in 1 other Very small study; it cannot estimate how often this happens
Hoyos et al., 2012 (randomized, placebo-controlled) 67 obese men with severe OSA Long-acting testosterone undecanoate injections vs. placebo 18 weeks At 7 weeks, oxygen drops rose by 10.3 per hour and time below 90% oxygen rose by 6.1 percentage points vs. placebo. Differences were not statistically significant at 18 weeks Early follow-up matters, but monitoring must continue beyond two months
Melehan et al., 2016 (same trial) Same 67 men Same 18 weeks Sexual desire improved Benefit and risk can show up together
Cole et al., 2018 3,422 men receiving TRT and 3,422 matched controls, ages 40–64; military service members, retirees, and dependents Real-world TRT Median 17 months 2-year risk of a new sleep apnea diagnosis: 16.5% on TRT vs. 12.7% without A real association, but not proof of cause
Liu and Reddy, 2022 (expert review) Review of the field — — Studies of short-term high doses found worsening; findings at replacement doses are mixed and may change over time A review, not a new trial or proof that replacement dosing is apnea-safe

A quick note on the numbers. The 2012 trial measured the oxygen desaturation index (ODI), which counts how often your blood oxygen dips each hour. That isn't the same as AHI. So "10.3 more events per hour" was an oxygen measure, not a jump in your apnea severity grade.

Does the dose or format matter?

Short-term high-dose studies have found worsening, and the 2012 replacement-dose trial also found worse oxygen measures at 7 weeks. Its later nonsignificant result does not establish that this effect is always temporary. Research review · Trial

You'll see clinics claim their daily microdosing, cream, or "steady levels" approach is easier on sleep apnea. Here's the honest answer: the evidence reviewed here does not establish that any testosterone format prevents sleep apnea from getting worse. Steady levels are a reasonable preference. They are not proven protection. Review · Testim warning

We checked a gel label to make the point. The current label for Testim, an FDA-approved testosterone gel revised July 2025, carries the same sleep apnea warning as injections. Its patient counseling section also lists "breathing disturbances, including those associated with sleep or excessive daytime sleepiness." Switching from shots to gel does not remove the warning. Testim, §§5.12 and 17.3

Why testosterone can affect breathing at night

Researchers are studying changes in breathing control, including how the body responds to low oxygen. Testosterone can also cause salt and water retention, but that does not prove why apnea worsens in a particular person. None of these lets anyone predict how your breathing will respond. That's why monitoring matters more than theory. Breathing research review · Testim, §§5.9 and 5.12

Did the 2025 and 2026 FDA label changes remove the sleep apnea warning?

Answer: No—the current Testim label still carries its sleep-apnea warning. The FDA's February 2025 labeling action addressed cardiovascular-risk language and blood pressure; HHS and FDA requested further changes in June 2026 covering age-related low testosterone, prostate cancer, and enlarged prostate. Neither announcement requested removal of the sleep-apnea warning. FDA 2025 notice · HHS 2026 announcement · Testim

You may have seen headlines saying testosterone warnings are being loosened. Some are. This one isn't.

TRT and sleep apnea table 4: Did the 2025 and 2026 FDA label changes remove the sleep apnea warning?
Date What changed Did it touch sleep apnea?
Feb 28, 2025 FDA requested class-wide updates: add TRAVERSE results, remove cardiovascular boxed-warning language, and add blood-pressure information No
July 2025 Testim gel label revised: old cardiovascular-risk section removed, blood pressure section added No. The sleep apnea warning (section 5.12) stayed
June 18, 2026 HHS/FDA requested label updates: remove the age-related limitation of use, update prostate cancer information, revise enlarged-prostate warnings No. The release lists only those three changes

We checked the HHS release and the relevant sections of the current Testim label on October 5, 2026. Requested changes still have to be submitted by drugmakers and reviewed by the FDA, so check the label for your exact product. In the Testim label checked for this page, the sleep apnea warning stands. HHS announcement · Testim, §5.12

Can sleep apnea cause low testosterone?

Answer: Sleep apnea is linked to lower testosterone, but the link does not prove that apnea is the cause in each person. The Endocrine Society lists some sleep disorders and severe obesity among potentially reversible contributors to low testosterone, and some studies find an apnea association after accounting for weight and age. That's why a sleep test sometimes belongs before a testosterone prescription, not after. Guideline, Table 1 · Research review · Amodeo study

This is the trap a lot of men fall into. Sleep apnea and low testosterone can feel almost the same.

Same symptoms, different cause

TRT and sleep apnea table 5: Same symptoms, different cause
Symptom Can occur with low testosterone? Can occur with sleep apnea? What it tells you
Tired all day Yes; nonspecific Yes Does not tell you which condition is present
Poor focus, brain fog Yes; nonspecific Yes Does not diagnose low testosterone
Low mood Yes; nonspecific Yes Needs a broader health assessment
Lower sex drive Yes Can occur Discuss sleep, hormones, medicines, and other causes
Sleepy, dozing off Can occur; nonspecific Yes Report drowsy driving promptly
Loud snoring Not a defining low-testosterone symptom A sleep-apnea clue Ask about sleep evaluation, not just hormone testing
Waking up gasping Not a defining low-testosterone symptom A sleep-apnea clue Report this to your clinician
Morning headaches Not a defining low-testosterone symptom Can occur Does not diagnose either condition

This is a symptom-overlap guide, not a frequency table or diagnostic checklist. Sources: Endocrine Society symptom table, NHLBI sleep-apnea symptoms, and MedlinePlus.

The Endocrine Society lists "sleep disturbance, increased sleepiness" as nonspecific symptoms of low testosterone, meaning they can come from many causes. If snoring, gasping, or witnessed pauses are part of your story, sleep apnea may explain some of what you're feeling. That's worth knowing before you pay for hormones. Endocrine Society, symptom table

Will CPAP raise my testosterone?

Maybe. This is one of the few spots where the evidence just moved.

TRT and sleep apnea table 6: Will CPAP raise my testosterone?
Study What they found
Zhang et al., 2014 meta-analysis (7 studies, 232 men) No statistically significant change in total testosterone after CPAP
Cignarelli et al., 2019 meta-analysis (12 studies, 388 men) No statistically significant change in total testosterone after CPAP
Amodeo et al., 2026 (Journal of Clinical Endocrinology & Metabolism; published online November 2025) Among 204 hospitalized men with severe obesity, severe or poorly controlled apnea was tied to lower testosterone, even after accounting for weight. In 14 newly diagnosed men who used CPAP well for 3 months, total testosterone rose by an average of 3.75 nmol/L (about 108 ng/dL)

Our read: the older reviews pooled small studies with limited or varied information on CPAP use; the 2019 review could identify adequate adherence in only three studies. The newer study's 14-person follow-up had no untreated comparison group, so it cannot show that CPAP alone caused the increase or explain why its result differed from the reviews. It's 14 people in one hospital, so it's a signal, not a rule. 2019 review · 2026 study

The practical takeaway is simple. Treat sleep apnea for its own sake, not as a promise that testosterone will rise. Better control can improve breathing and daytime sleepiness; ask your clinician when testosterone should be reassessed. You may or may not still meet the criteria for TRT. NHLBI CPAP guidance · Endocrine Society

That evaluation should follow the standard rules: compatible symptoms or signs plus consistently low testosterone, confirmed with repeat testing. The Endocrine Society recommends separate early-morning, fasting measurements, using accurate tests and avoiding testing during an acute illness. One result—or a cutoff such as 300 ng/dL—does not diagnose everyone. Our TRT blood test guide walks through how low testosterone is properly confirmed. Diagnostic recommendations

Do you need a sleep study before starting TRT?

Answer: Not every man needs a sleep study before TRT. Loud snoring, witnessed breathing pauses, or daytime sleepiness should prompt a clinician to assess whether testing is needed, especially when other risk factors are present. A positive screen means "consider diagnostic testing," not "you have sleep apnea." AASM diagnostic guideline · NHLBI symptoms

The quick risk check doctors use

STOP-Bang is an 8-question yes-or-no screen that sleep clinics and surgeons use. It asks about:

  • Snoring that's loud
  • Tiredness during the day
  • Observed pauses in breathing
  • High blood Pressure
  • BMI over 35
  • Age over 50
  • Neck size of 16 inches / 40 cm or larger in the AASM-hosted version
  • Gender (male)

A score of 3 or more calls for closer attention; it is not always the questionnaire's highest-risk category. Early surgical-patient validation found about 93% sensitivity for moderate-to-severe apnea and 100% for severe apnea, but those figures are not guarantees for other populations. It also flags plenty of people who do not have apnea. That's why it's a screen, not a diagnosis. Use the complete STOP-Bang questionnaire hosted by AASM, including its scoring rules, rather than scoring yourself from this summary. Validation research

Home sleep test or sleep lab?

Many adults with a high chance of apnea and no major heart, lung, or nerve conditions can use a home sleep apnea test. You wear a small device for a night or two in your own bed. The AASM recommends an overnight study in a sleep lab rather than a home test for people with significant heart or lung disease, chronic opioid use, possible breathing-muscle weakness, suspected hypoventilation, a history of stroke, or severe insomnia. AASM recommendations 2 and 4

One catch: a home test can miss apnea. The AASM recommends an in-lab study after a single negative, unclear, or technically inadequate home test when evaluating suspected OSA. A negative home result is not a reason to ignore ongoing symptoms. AASM recommendation 3

What to ask a TRT program about screening

Ask how the clinician reviews sleep symptoms and when a sleep study is needed before starting testosterone. A questionnaire alone is not enough to diagnose or exclude OSA. That is a clearer standard than assuming every program must use one named questionnaire. AASM diagnostic guideline

Why does hematocrit matter when you have sleep apnea?

Answer: Testosterone can raise red blood cell levels, and sleep apnea with low nighttime oxygen can contribute to an elevated blood count too. That makes hematocrit, the share of your blood made of red cells, important before and during TRT. It is one part of monitoring—not a test that diagnoses apnea or proves TRT is safe. Endocrine Society monitoring guidance · Lundy study

Think of it as two possible contributors, not a prediction. TRT can raise hematocrit, and low oxygen can contribute; a rising result needs a clinician to look at the whole picture. A normal blood count does not rule out sleep apnea. Guideline · Sleep-testing guidance

The numbers that matter

  • Before starting: The Endocrine Society lists a hematocrit above 48% (above 50% if you live at high altitude) as a moderate-to-high risk for starting testosterone. The AUA advises considering withholding a new prescription when baseline hematocrit is above 50% until the cause is explained. These are clinician decision points, not self-clearance cutoffs. Endocrine Society, Table 7 · AUA guideline
  • On treatment: The AUA treats an on-treatment hematocrit of 54% or higher as a level that needs clinician action. The Endocrine Society's monitoring plan pairs a result above 54% with a clinician-directed pause and checking for low oxygen and sleep apnea, not just changing the dose. Do not wait for that number to report worsening symptoms. AUA · Endocrine Society monitoring table
  • How often to check: The Testim gel label says to check hematocrit before starting, again 3 to 6 months after starting, and then once a year. Some products and some patients need more frequent checks. Testim, §5.2
  • What the trials found: In the Endocrine Society's commissioned review of transdermal-testosterone trials, the relative risk of hematocrit above 54% was about 8 times that with placebo. The estimate was imprecise: 8.14, with a 95% confidence interval of 1.87–35.40. It is not the percentage of men affected or a risk estimate for every format. Guideline evidence review

A rising hematocrit can be a sleep apnea clue

A Cleveland Clinic research group looked back at 474 men on TRT. Sixty-two men—13.1%—met the study's definition of polycythemia: hematocrit of 52% or higher. OSA was associated with higher odds of that finding after adjustment for age, body mass index, and peak testosterone (odds ratio 2.09; 95% confidence interval 1.17–3.76). That is an association from one practice, not proof that apnea caused the rise or a universal rate for TRT patients. Lundy et al., 2020

So if your hematocrit keeps creeping up on TRT, "lower the dose" or "donate blood" shouldn't be the whole answer. The better question is: is my sleep apnea undiagnosed or not controlled? Ask your clinician about other causes too; do not use blood donation as a self-directed way to manage the result. Endocrine Society monitoring guidance

Format may play a part, too. The Endocrine Society notes that testosterone gels cause less erythrocytosis (high red cell counts) than injections. If your hematocrit runs high, that's a fair thing to raise with your prescriber. It does not make gel proven protection against worsening apnea. Endocrine Society, formulation table · Testim, §5.12

For the full picture on blood counts, blood pressure, and other monitoring, see our TRT safety and monitoring guide.

What should happen before and after starting TRT?

Answer: Review sleep symptoms, address untreated or poorly controlled apnea, confirm low testosterone properly, and get the required baseline assessment before a clinician decides whether to prescribe. Some testing can happen in parallel; not everyone needs a sleep study. Early follow-up matters, and so does monitoring beyond the first few months. Endocrine Society · AASM · Testim monitoring

Here's the sequence we'd want any care program to explain:

  1. Screen your sleep. If you snore, gasp, or are sleepy during the day, tell your clinician and ask whether a sleep test is needed.
  2. Treat the apnea and make sure it's working. Follow your prescribed sleep treatment and bring follow-up data. For CPAP, use it whenever you sleep, as directed by your sleep clinician.
  3. Confirm low testosterone the right way. That means compatible symptoms or signs plus consistently low results on separate, appropriate early-morning tests. Ask how sleep treatment affects the timing of reassessment.
  4. Get baseline labs, including hematocrit. Add PSA and other tests your clinician recommends for your age and history. Review blood pressure, other health risks, and fertility plans too.
  5. If your clinician prescribes, agree on follow-up first. Know when symptoms, testosterone, and hematocrit will be reviewed. Report new snoring or gasping right away rather than waiting for a scheduled 3-to-6-month check. Diagnostic and monitoring guidance · CPAP use · Testim

Signs your sleep apnea may be getting worse on TRT

  • Louder snoring, or snoring that's new
  • A partner noticing you stop breathing
  • Waking up gasping or choking
  • Morning headaches
  • Daytime sleepiness coming back
  • Your CPAP data showing more breathing events than before
  • Hematocrit creeping up on your lab reports

These are reasons to ask for assessment, not proof that TRT caused apnea or that apnea is the only explanation. NHLBI symptoms · Lundy study

What to do if it happens

Message your TRT prescriber, and loop in whoever manages your sleep apnea. Bring a short timeline of when things changed. Don't stop, lower, or change your testosterone on your own, and don't adjust your CPAP pressure yourself. Your clinicians may adjust your apnea treatment, change the dose or format, or pause TRT while they sort it out. That's their call to make with you. Severe or sudden breathing trouble, chest pain, or stroke symptoms need emergency care, not a portal message. Testim safety information · Sleep-apnea emergency guidance

What should you bring to a sleep-and-TRT appointment?

Answer: Bring your sleep study report, your CPAP or treatment usage data, recent lab results with dates, and your exact testosterone product name. Then ask who will review your sleep treatment and who will manage TRT follow-up. This list helps you have the conversation. It doesn't decide whether TRT is safe for you.

Most clinic visits are short. Walking in with the right papers changes the conversation from "do you snore?" to "here's my data, what's your plan?" Print this or screenshot it.

Bring:

Ask:

  1. What do you know about my apnea type, severity, and how well my treatment is working?
  2. Will you check my hematocrit before my first prescription?
  3. When is my first recheck, and what's included?
  4. Will you review my sleep study and CPAP data?
  5. Is the testosterone FDA-approved or compounded?
  6. If my snoring or hematocrit gets worse, who do I contact, and how fast will I hear back?
  7. Do my fertility plans change anything?

Write down before you leave:

  • Who reviews my sleep treatment: ________ Next date: ________
  • Who manages my TRT and labs: ________ Next date: ________
  • What I should report right away, and to whom: ________

Which TRT providers check the right things for sleep apnea?

Answer: A useful program needs a plan for both sleep care and testosterone care—not just a large hormone panel. Hone Premium publicly lists baseline hematocrit and first-year quarterly CBC checks; Male Excel's starter home kit does not list hematocrit, although it also advertises a broader members-only panel. Neither fact tells us whether a specific clinician will accept your apnea history or coordinate with your sleep doctor. Hone Premium labs · Male Excel starter kit · Male Excel membership

The options below are a public-information comparison, not a recommendation that any clinic is safe for your apnea. If you're in row 2, 6, 7, 8, or 9 of the situation table, resolve the sleep or blood-count concern with your clinician before shopping for a new prescription. The providers below will still be here.

Affiliate disclosure: TRT Provider Guide may earn a commission through affiliate links in our linked provider guides. That doesn't change our situation table, our sources, or which care route fits which reader. Read our affiliate disclosure and how we review providers in How We Review TRT Providers.

What we actually verified

Date checked: October 5, 2026

Sources: Relevant Endocrine Society recommendations; the published AUA guideline; FDA prescribing information and labeling announcements; the HHS June 18, 2026 release; AASM diagnostic guidance; the primary studies or their published abstracts; DEA's current extension and the Federal Register rule; and the provider pages, plan documents, pricing, and terms linked below.

Verified facts: The cited guideline and label wording, scope of the 2025 and 2026 announcements, study populations and reported results, and our arithmetic using the stated assumptions.

Provider-stated facts: Prices, test-panel contents, visit and retest schedules, state restrictions, treatment offerings, pharmacy lists, and billing or cancellation terms. We verified what public pages say, not that each service will be delivered to every patient.

Not confirmed: Each provider's acceptance criteria for people with OSA; review of CPAP data; acceptance of an outside CBC; patient-specific repeat-test timing and fees; the exact prescribed product and assigned clinician or pharmacy; response and refill turnaround; and a complete personalized 365-day care quote. We did not enroll as patients, test an intake, request medical records, or have a clinician review this page.

The sleep apnea provider check

TRT and sleep apnea table 7: The sleep apnea provider check
Hone Health — Premium plan Male Excel Taurus Meds Local doctor + insurance, when covered
Hematocrit in starting labs? Yes. The Premium initial venous panel lists a CBC with hematocrit, hemoglobin, and red blood cell count. Not listed in the starter kit. Its five named markers are total testosterone, estradiol, DHEA-S, free T3, and PSA. The separate 54-marker offer is described as members-only. Exact baseline markers not established by the public offer checked. Ask for the clinician's baseline panel; do not assume a CBC is included in every visit or quoted fee.
Labs before the prescription? Premium requires initial labs before the first visit and a confirmatory testosterone/prolactin draw if TRT is considered. Male Excel says providers may prescribe from symptoms and history before results arrive. That statement is not a substitute for guideline-based confirmation of low testosterone. The $49 offer describes testing and clinical review, but it does not establish two appropriately timed diagnostic testosterone measurements. Ask how symptoms, consistently low results, and repeat morning testing are assessed.
Recheck schedule Premium lists CBC, metabolic, and hormone panels at months 3, 6, 9, and 12, then 18 and 24. Advertises provider check-ins every 60 days and fuller member panels every 6 months. Ask whether hematocrit is included and whether your first CBC needs to be earlier. Confirm the exact tests and dates before paying. Set by your clinician and the product's monitoring needs.
Clinician access and sleep coordination Initial live video consultation and follow-up visits are provider-stated. OSA-specific coordination was not confirmed. Unlimited provider access and 60-day check-ins are provider-stated, not a guaranteed response time or sleep-specialist service. Clinical review is advertised; an assigned clinician and sleep-care process were not verified. Ask who will review sleep records and who will manage testosterone monitoring.
Testosterone formats Testosterone cypionate injections; separately, compounded cream and troches. Advertises injections and Lipoderm cream, with daily administration in its program description. This is not a dosing recommendation. Advertises injectable testosterone and gel; the campaign contains inconsistent product descriptions. Ask which prescribed formats are appropriate and available through your plan and pharmacy.
FDA-approved or compounded? The plan explicitly labels cream and troches as compounded. Verify the manufacturer and approval status of the exact injectable product; the ingredient name alone does not settle it. The site describes its hormones as compounded in the United States. Do not assume an FDA-approved product from the name "testosterone cypionate"; request the exact product and pharmacy. The homepage advertises FDA-approved medications, while the campaign also describes compounded medication. Product-level status remains unresolved. FDA-approved products may be prescribed; coverage and the exact product must still be checked.
Published price $65 initial testing/consult offer; the Premium schedule adds a $25 confirmatory test when TRT is considered; membership $155/month, medicines extra. The plan quotes cypionate from $28 per vial, while the TRT landing page says from $28 per month. Compounded cream and troches are listed at $60/month; Premium lists free shipping. $99 test-and-consult package; $99/month membership. The advertised $120/month injectable and $132/month cream prices are testosterone-plus-thyroid medication bundles, not verified TRT-only quotes; shipping is extra. One official campaign advertises $49 testing/consult and $149/month if prescribed. It says no membership fees, but the general terms list $17.99 per billing period unless purchase terms say otherwise. Confirm visit, repeat-test, medicine, equipment, deductible, copay, and out-of-network costs with the clinic and plan.
First-year cost check $65 + $25 + (12 × $155) = $1,950 before medication under the Premium schedule. The per-vial/per-month conflict prevents a confirmed injectable total. $99 + (12 × $99) = $1,287 before medication. Six $240 fills of the advertised injectable-plus-thyroid bundle would make $2,727 plus shipping; that is 360 medication days, not a full 365-day prescription quote. $49 + (12 × $149) = $1,837 under the campaign's stated terms. This is conditional, not a verified complete total, until the campaign-specific membership-fee exception and all required labs and fees are confirmed. Cannot be calculated without your coverage and a care plan.
States Its September 2026 list covers 34 states for men's Premium; other plans differ. Check the plan-specific state list before paying. Homepage excludes AL, AK, AR, CT, HI, ID, LA, MN, MS, NH, and RI. Confirm your location before paying. Confirm your state and the clinician's authority before paying. The clinician must be authorized to treat you where you are; coverage and appointment access vary.
Insurance Membership is priced separately from medicines; do not assume your health plan pays the program fees. Says it does not accept insurance. It advertises FSA/HSA/HRA payment options; check your account's rules. An insurance payment pathway was not established by the offer checked. Possible, not guaranteed; confirm both clinician network status and drug coverage.
Commitment, cancellation, and refunds Cancel-anytime membership; terms make cancellation effective at the billing-period end and generally make paid fees nonrefundable. Advertises no contract, cancellation or pause at any time, and a conditional 90-day membership-fee guarantee. Confirm the effective date and pending medication charges; this is not an unconditional drug refund. Refund policy requires cancellation at least 72 hours before billing to avoid the next charge. Campaign guarantees and general refund terms do not match cleanly; get the applicable terms in writing. Ask about visit cancellation, lab billing, prescriptions already filled, and any separate clinic membership.

Source map: Hone's Premium plan, Premium lab schedule, TRT pricing page, and terms; Male Excel's starter test, membership/state information, pricing, and terms; Taurus's homepage, $49 campaign, terms, and refund policy. The local-care column is a checklist, not a claim about every local practice.

Prices and terms are provider-stated and were checked October 5, 2026. Male Excel's pricing page displays a May 2025 update date. The figures above are transparent subtotals or stated-offer scenarios—not complete, comparable 365-day treatment quotes. A missing fee is unknown, not zero.

Before paying, ask for one written quote that includes the first test, repeat diagnostic testing, baseline CBC, visits, ongoing monitoring, the exact medicine and quantity, supplies, shipping, taxes, and renewal charges. Ask separately about a sleep study or sleep-care follow-up; these were not established as included in any listed TRT price. Use our TRT cost guide to organize the whole bill.

A pharmacy list is not your dispensing pharmacy. Taurus's terms name Red Rock Home Pharmacy, HealthWarehouse, Precision Compounding Pharmacy, and Triad Rx. That does not tell us which one would fill your prescription or establish its current license for your state. For any program, request the assigned clinician's name, the dispensing pharmacy, how to obtain your lab and visit records, and the steps required for the next refill. These patient-specific details were not verified here. Taurus partner disclosures

Hone Health: documented labs before the prescription, but check the plan

Hone Premium's published order is a useful comparison point: a venous blood panel with hematocrit first, then a physician visit that reviews those results, confirmatory testing if TRT is considered, and medication only after the clinical decision. Its schedule includes a CBC at each first-year quarterly follow-up. That supports a lab-process comparison, not a claim that Hone is the safest provider for sleep apnea. Premium schedule

What to know before you sign up: Premium costs $155 a month plus medication, with the $65 initial offer and $25 TRT confirmatory draw described above. Hone also offers a lower-priced Plus plan; do not assume every plan has Premium's starting CBC or monitoring schedule. Its Plus documents publish differing confirmatory-test prices, so ask which charge applies. Membership comparison · Plus plan · Plus TRT lab schedule

Hone also sells clomiphene and enclomiphene. Those are not testosterone replacement therapy, so make sure you know which treatment is being proposed. Clomiphene's use for male low testosterone is off-label; enclomiphene has no FDA-approved drug product. Hone's physicians work in independently owned practices that use Hone's platform. The patient stories on Hone's site are labeled as compensated, so we don't use them as evidence of effectiveness or safety. Clomid label · FDA enclomiphene review · Current government drug-status explanation · Hone terms · Hone testimonial disclosure

Best for: Comparing a clearly published Premium lab sequence after a clinician has addressed your apnea and determined whether TRT is appropriate. Not for: Treating a $65 test purchase as clearance to start TRT, or bypassing care for untreated severe apnea.

Want to check the lab sequence before choosing a program? Compare the starting tests, confirmatory draw, follow-up schedule, and extra costs. Review Hone's testing, costs, and limits →

Male Excel: ask about the starter-lab gap before choosing the program

Male Excel does not list hematocrit in its starter home test, and it says its providers may prescribe before lab results come back. A recent normal blood count does not resolve the need to confirm low testosterone properly or establish that your apnea is controlled. Ask for the full diagnostic and monitoring plan before paying; a clinician who reviews the required results first is the appropriate alternative when that plan is missing. Starter kit · Prescribing statement · Diagnostic standard

Male Excel's $99 monthly membership advertises unlimited provider access, a check-in every 60 days, and fuller panels every 6 months. The separate 54-marker panel is described as members-only, not the five-marker starter kit. Those are useful follow-up features to compare, but they do not prove that baseline hematocrit is reviewed or that an outside blood panel will replace a program charge. Membership and panel descriptions

What to know before you sign up: Male Excel describes its hormones as compounded, not FDA-approved products. Its program describes small daily doses; that is a provider approach, not evidence of protection against worsening sleep apnea. Its own safety information lists sleep apnea as a possible side effect and tells patients to report breathing problems during sleep. Ask whether hematocrit is part of the 6-month member panel and whether your clinician requires an earlier check. Its public panel description lists categories but does not settle your individual monitoring plan. Male Excel also notes that federal and state requirements can lead to an in-person examination for some patients. Provider statements · FDA compounding guidance

The advertised $120 and $132 monthly medication prices include thyroid medication. Do not add thyroid treatment simply to match a package: ask for the price of the treatment your clinician actually recommends. The $99 entry offer already includes the test and consultation; we have not added a second unknown test-kit fee. Pricing · Test-and-consult offer

Best for: Comparing provider access and follow-up after you have a clear, clinician-approved diagnostic and sleep-monitoring plan—not simply because you own a CPAP or have one normal CBC. Not for: Skipping repeat diagnostic testing, leaving severe apnea untreated, or ignoring new breathing symptoms or a rising hematocrit.

Considering Male Excel? Resolve the starter-test gap, exact medication, and full bill before a clinical intake. Review Male Excel's testing and full costs →

Taurus Meds: ask first

Taurus publishes a $49 testing-and-consult offer with a stated $149 monthly treatment price if prescribed. Its homepage advertises FDA-approved medications, while the campaign also describes compounded medication. The campaign says no membership fees, while the general terms list $17.99 per billing period unless the purchase terms say otherwise. Confirm that the no-fee campaign terms apply to your order. None of those claims proves which product or fee schedule you would receive. Campaign · Homepage · Terms

If you're considering Taurus, ask two questions before you pay: Is hematocrit in my starting labs? and When is my first recheck? Also ask for the exact product, repeat morning-test requirements, dispensing pharmacy, and the written all-in bill. Its published cancellation policy calls for at least 72 hours' notice before billing; do not assume a campaign guarantee refunds tests or medication. Refund policy

The local or insurance route

Some men with sleep apnea are better off starting locally. That includes:

  • Severe apnea, even if it's treated, when you also have heart, lung, or kidney disease
  • Anyone taking opioids or sedatives who needs closer review of breathing risks
  • Anyone who wants to check coverage for an FDA-approved product through insurance
  • Anyone who wants their sleep doctor and hormone doctor in the same health system

These are care-coordination judgments, not a claim that every listed condition rules out telehealth. A primary care doctor, urologist, or endocrinologist can coordinate with your sleep clinic. Our guide to urologist vs. endocrinologist for low testosterone can help you decide which specialist fits. For the bigger trade-offs, see online vs. local TRT care.

What if weight is driving both problems?

Answer: For adults with obesity and moderate-to-severe obstructive sleep apnea, the FDA approved Zepbound (tirzepatide) in December 2024 as the first medicine for that condition. Zepbound is not testosterone and doesn't replace TRT or automatically replace prescribed sleep treatment. Because severe obesity can contribute to low testosterone, ask whether treating weight and apnea changes your evaluation. FDA approval · Endocrine Society

The approval came on December 20, 2024. It was based on two 52-week trials in 469 adults with obesity and moderate-to-severe obstructive sleep apnea who did not have type 2 diabetes. People on Zepbound had fewer breathing events during sleep than people on placebo. The FDA said the improvement is likely tied to weight loss. Zepbound is meant to be used with diet and exercise. Its sleep-apnea indication does not cover mild apnea or adults without obesity. FDA approval and trial population

Why does this belong on a TRT page? Extra weight is a common cause of both sleep apnea and low testosterone. The Endocrine Society lists severe obesity and some sleep disorders as reversible causes of low testosterone. For some men, treating the weight and the apnea comes first, and the testosterone question looks different afterward. Endocrine Society causes of hypogonadism

To keep things clear: Zepbound, clomiphene, and enclomiphene are not TRT. Zepbound has the specific FDA-approved OSA use described above. Clomiphene is FDA-approved for certain ovulation problems in women, not male low testosterone; enclomiphene has no FDA-approved drug product. Compounded versions are not FDA-approved. Our TRT treatment options guide keeps them sorted. Clomid label · FDA enclomiphene review · Current government drug-status explanation · FDA compounding guidance

Does sleep apnea change anything if you want kids?

Answer: The key issue is that TRT itself can suppress sperm production, whether or not you have sleep apnea. The Endocrine Society recommends against starting testosterone when fertility is planned in the near term. Talk with a reproductive urologist or another fertility-aware clinician before you decide. Endocrine Society · Testim, §8.3

The Endocrine Society recommends against TRT for men planning fertility in the near term. Testosterone labels warn it can lower sperm count, and the Testim label notes the effect on fertility may be irreversible. Recovery may occur, but neither the timing nor full recovery can be promised. Testim, §8.3

If kids are in your future, raise it before the first prescription. Our TRT and fertility guide covers your options.

Can you get TRT online if you have sleep apnea?

Answer: Sometimes, but online access is not the same as medical suitability. Federal rules extend qualifying audio-video telemedicine prescribing of Schedule II–V controlled substances without a prior in-person evaluation through December 31, 2026, subject to applicable requirements. State law, the clinician's authority, program policy, and your health needs still matter. DEA announcement · Federal Register rule

Testosterone is a Schedule III controlled substance and requires a valid prescription from a clinician with the necessary prescribing authority. A questionnaire or paid membership cannot guarantee that prescription. Testim, §9.1 · Federal prescribing conditions

The current telemedicine flexibility runs through December 31, 2026. Do not assume the same rules will apply to a 2027 refill, or that an audio-only call is enough for testosterone under this extension. Before paying, confirm the requirements where you will physically be during the visit and how the program handles any in-person examination. For the full process, see how to get TRT safely and legally. DEA extension and conditions

How did we verify this page?

Answer: We checked the relevant guideline recommendations, label sections, official announcements, and published study results, then compared the provider documents cited on this page on October 5, 2026. Provider claims remain provider-stated unless an independent source supports them. The situation table and care-route judgments use our documented method, How We Review TRT Providers, not a medical score or a clinical eligibility test.

Here's exactly what we did:

  • Primary sources first. Guideline wording came from the Endocrine Society and AUA. Label wording came from FDA-approved prescribing information. Study numbers came from the published papers or abstracts.
  • We checked what didn't change. We compared the stated scope of the 2025 FDA and 2026 HHS/FDA announcements with the sleep-apnea warning in the current Testim label.
  • We calculated cost ourselves. We separated confirmed published subtotals from conditional offer math. We did not treat an unknown fee as zero, a vial as a month, a testosterone-plus-thyroid bundle as TRT-only, or 360 medication days as 365 days.
  • We kept categories separate. Verified facts, provider-stated facts, and our editorial conclusions are labeled as different things.
  • We did not enroll as patients, test a clinic's intake, or have a clinician review this page.

Read How We Review TRT Providers and our editorial standards. If you spot an error or an outdated price, tell us through our corrections page.

Frequently asked questions

The main questions are whether apnea is controlled, whether low testosterone is properly confirmed, and what will be monitored. These answers do not replace the individual assessment described above.

Does TRT cause sleep apnea?

It may contribute in some men. A study compared 3,422 men on TRT with 3,422 matched controls in the U.S. military health system and found more new sleep apnea diagnoses in the TRT group (16.5% vs. 12.7% over two years), but it couldn't prove TRT was the cause. The Testim label highlights obesity and chronic lung disease as risk factors. Cole study · Testim, §5.12

Can I take TRT if I use a CPAP?

CPAP use does not automatically clear you for TRT. The Endocrine Society's sleep-apnea exclusion is untreated severe OSA, but your clinician must still confirm that apnea is controlled, diagnose low testosterone properly, and assess other risks. Bring your usage summary and get your hematocrit checked. Guideline · CPAP guidance

Does sleep apnea lower testosterone?

It's linked to lower testosterone, and weight and broken sleep can contribute. A study published online in 2025 and in a 2026 journal issue found an association even after accounting for weight. That does not establish the cause of your own low result; ask your clinician about sleep treatment and properly timed testosterone testing. Amodeo study · Guideline

Will CPAP raise my testosterone?

Older reviews found no statistically significant average increase. A newer uncontrolled follow-up of 14 men using CPAP for 3 months found testosterone rose by about 108 ng/dL on average. That small result does not promise the same change for you; CPAP should be used for the sleep condition it was prescribed to treat. 2019 meta-analysis · 2026 study

How soon could TRT make my sleep apnea worse?

One controlled trial found worse oxygen measures at its 7-week assessment, but it did not establish when worsening first began or peaked. The 18-week between-group differences were not statistically significant, not proof that all risk was gone. Report changes whenever they occur, including after the first few months. Hoyos trial

Is testosterone gel safer than injections for sleep apnea?

The evidence reviewed here does not establish that a testosterone format prevents worsening sleep apnea. The current Testim gel label carries a sleep-apnea warning. Gels tend to cause less erythrocytosis than injections, which may matter if your hematocrit runs high, but that is not proof of less apnea risk. Testim · Endocrine Society formulation table

Should I stop TRT if I start snoring?

Don't stop or change your dose on your own. Tell your prescriber promptly, and ask about a sleep test and a hematocrit check. If you have trouble breathing right now, get emergency help. Testim safety information

Can my blood count be normal and I still need a sleep test?

Yes. A blood count can't diagnose or rule out sleep apnea. Your clinician uses your history and the appropriate sleep test; symptoms or a questionnaire alone cannot establish the diagnosis. AASM diagnostic guideline

Did the FDA remove the sleep apnea warning in 2026?

No. The June 2026 request covered age-related low testosterone, prostate cancer, and enlarged prostate. The sleep apnea warning wasn't part of it, and it's still in the current Testim label checked for this page. HHS announcement · Testim

Does TRT help you sleep better?

Don't count on it. TRT is not a treatment for obstructive sleep apnea, and the Endocrine Society's commissioned trial review found no statistically significant improvement in energy. If you're tired and snore, ask about sleep apnea rather than assuming hormones will fix your sleep. Guideline evidence review · Testim warning

Does this page apply to women or transgender men?

This page covers evaluation and treatment of adult male hypogonadism, not gender-affirming testosterone care, treatment in women or adolescents, or nonmedical performance use. Those situations need guidance specific to the person and the reason for treatment; the care-route comparisons here should not be used to determine eligibility for them.

What is the bottom line?

Sleep apnea doesn't automatically rule you out of TRT, but the Endocrine Society recommends against starting it with untreated severe apnea. Treated or milder apnea still requires a proper low-testosterone diagnosis, review of other risks, and a plan for sleep care and blood-count monitoring. Check what a program will assess before paying—not just whether it will prescribe. Endocrine Society · Testim monitoring and sleep warning

The best question to ask any TRT program isn't "Will you prescribe testosterone?" It's "What will you check before you do, and what will you do if my breathing or blood count changes?"

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

Sources

The claims and public documents cited here were checked on October 5, 2026. Original publication and label-revision dates are shown so older evidence is not mistaken for a new study.

  1. Endocrine Society: Testosterone Therapy for Hypogonadism and the full 2018 clinical practice guideline. Diagnostic recommendations, untreated severe OSA, fertility, causes, formulation comparisons, and hematocrit monitoring.
  2. American Urological Association: Evaluation and Management of Testosterone Deficiency. Published 2018 guideline; diagnostic and hematocrit recommendations. The AUA guideline landing page is the society's update location.
  3. FDA-approved testosterone cypionate prescribing information, NDA 216318. Archived label revised June 2022, §5.10; not presented as the current version of every injectable label.
  4. Testim prescribing information on DailyMed. Revised July 2025; §§4, 5.2, 5.12, 8.3, 9.1, and 17.3.
  5. FDA: Class-wide labeling changes for testosterone products. February 28, 2025.
  6. HHS: Requested updates to testosterone therapy product labels. June 18, 2026.
  7. Matsumoto et al.: Testosterone replacement in hypogonadal men—effects on obstructive sleep apnoea, respiratory drives, and sleep. Clinical Endocrinology, 1985; published abstract.
  8. Hoyos et al.: Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea. Clinical Endocrinology, 2012; randomized trial, published abstract and author-institution record.
  9. Melehan et al.: Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea. 2016; outcomes from the same trial population.
  10. Cole et al.: Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men. BJU International, 2018; published abstract.
  11. Liu and Reddy: Sleep, testosterone and cortisol balance, and ageing men. Reviews in Endocrine and Metabolic Disorders, 2022.
  12. Zhang et al.: Efficacy of continuous positive airway pressure on testosterone in men with obstructive sleep apnea. PLOS ONE, 2014; meta-analysis.
  13. Cignarelli et al.: Effects of CPAP on testosterone levels in patients with obstructive sleep apnea. Frontiers in Endocrinology, 2019; meta-analysis.
  14. Amodeo et al.: The role of obstructive sleep apnea and CPAP therapy in the functional hypogonadism of male patients with severe obesity. JCEM, 2026;111(5):1272–1277; published online November 24, 2025.
  15. Lundy et al.: Obstructive sleep apnea is associated with polycythemia in hypogonadal men on testosterone replacement therapy. Journal of Sexual Medicine, 2020; published abstract.
  16. AASM: Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea. 2017; recommendations on questionnaires, home testing, and polysomnography.
  17. STOP-Bang questionnaire hosted by AASM and Nagappa et al. validation meta-analysis, 2015. Questionnaire domains, scoring context, and population-dependent performance.
  18. Cleveland Clinic: Apnea-Hypopnea Index, updated February 21, 2025; NHLBI: CPAP and sleep-apnea symptoms; MedlinePlus: adult obstructive sleep apnea and central sleep apnea. Cleveland Clinic emergency guidance.
  19. FDA: First medication approved for obstructive sleep apnea. December 20, 2024; Zepbound indication and trial population.
  20. FDA: Understanding the risks of compounded drugs; Clomid prescribing information; FDA enclomiphene presentation, June 8, 2022, drug-applications section; and Operation Supplement Safety drug-status explanation, current January 12, 2026.
  21. DEA: Extension of telemedicine flexibilities, December 31, 2025, and the fourth temporary extension in the Federal Register, effective January 1–December 31, 2026.
  22. Hone Health: Premium plan, Premium laboratory schedule, plan comparison, Plus plan, Plus TRT lab schedule, state availability, TRT medication-pricing page, homepage, and terms. Provider statements, not an enrollment or clinical-outcome test.
  23. Male Excel: starter kit and consultation, membership, panels, state restrictions, and prescribing statements, medication-bundle pricing, and terms. Provider statements; the pricing page displays a May 2025 update date.
  24. Taurus Meds: homepage, $49 testosterone campaign, terms and partner disclosures, and refund policy. Conflicting public claims are identified rather than treated as settled purchase terms.

Not sure which TRT route fits you?

Find My TRT Path